中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
20期
24-26
,共3页
张博晴%孙烈%杨季明%程宏勇%胡文志%俞建%曹喆%黄艳秋
張博晴%孫烈%楊季明%程宏勇%鬍文誌%俞建%曹喆%黃豔鞦
장박청%손렬%양계명%정굉용%호문지%유건%조철%황염추
桡动脉%介入治疗%并发症
橈動脈%介入治療%併髮癥
뇨동맥%개입치료%병발증
Radial artery%Intervention treatment%Complication
目的:评估改良法经桡动脉介入治疗减少桡动脉并发症的临床应用价值。方法将1354例患者,随机表法分为普通组(经桡动脉介入组)和改良法组(改良法经桡动脉介入组),观察桡动脉并发症。结果改良组出现脑梗死和桡动脉闭塞等严重并发症明显低于普通组,前臂血肿、迷走神经反射、桡动脉痉挛和无需手术假性动脉瘤等一般并发症也明显低于普通组。两组均未出现骨筋膜综合征、需外科手术的假性动脉瘤。结论改良法经桡动脉介入治疗能有效地避免严重桡动脉并发症的发生。
目的:評估改良法經橈動脈介入治療減少橈動脈併髮癥的臨床應用價值。方法將1354例患者,隨機錶法分為普通組(經橈動脈介入組)和改良法組(改良法經橈動脈介入組),觀察橈動脈併髮癥。結果改良組齣現腦梗死和橈動脈閉塞等嚴重併髮癥明顯低于普通組,前臂血腫、迷走神經反射、橈動脈痙攣和無需手術假性動脈瘤等一般併髮癥也明顯低于普通組。兩組均未齣現骨觔膜綜閤徵、需外科手術的假性動脈瘤。結論改良法經橈動脈介入治療能有效地避免嚴重橈動脈併髮癥的髮生。
목적:평고개량법경뇨동맥개입치료감소뇨동맥병발증적림상응용개치。방법장1354례환자,수궤표법분위보통조(경뇨동맥개입조)화개량법조(개량법경뇨동맥개입조),관찰뇨동맥병발증。결과개량조출현뇌경사화뇨동맥폐새등엄중병발증명현저우보통조,전비혈종、미주신경반사、뇨동맥경련화무수수술가성동맥류등일반병발증야명현저우보통조。량조균미출현골근막종합정、수외과수술적가성동맥류。결론개량법경뇨동맥개입치료능유효지피면엄중뇨동맥병발증적발생。
Objective To evaluate the clinical application value of modified transradial coronary intervention in reducing radial artery complications. Methods A total of 1354 patients were divided into the ordinary group (transradial coronary intervention group) and the modified method group (modified transradial coronary intervention group) according to the random table method.The radial artery complications of the two groups were observed. Results The modified group was significantly lower than the ordinary group in the incidences of severe complications such as cerebral infarction and radial artery occlusion;The modified group was also significantly lower than the ordinary group in the incidences of ordinary complications such as forearm hematoma,vagal reflex,radial artery spasm and pseudoaneurysm not requiring surgery.No osteofascial syndrome or pseudoaneurysm requiring surgery appeared in either group. Conclusion Modified transradial coronary intervention can effectively avoid the occurrence of severe radial artery complications.